Bodycote (LON:BOY – Free Report) had its target price cut by JPMorgan Chase & Co. from GBX 760 ($9.78) to GBX 750 ($9.65) in a report published on Thursday morning, MarketBeat reports. They currently have a neutral rating on the stock.
Several other research firms have also commented on BOY. Royal Bank of Canada reiterated a sector perform rating and set a GBX 720 ($9.26) price objective on shares of Bodycote in a research note on Wednesday, July 31st. Jefferies Financial Group restated a buy rating and set a GBX 980 ($12.61) price objective on shares of Bodycote in a report on Friday, July 12th.
Read Our Latest Analysis on Bodycote
Bodycote Price Performance
Bodycote Cuts Dividend
The company also recently disclosed a dividend, which will be paid on Thursday, November 7th. Stockholders of record on Thursday, October 3rd will be issued a GBX 6.90 ($0.09) dividend. This represents a dividend yield of 0.97%. The ex-dividend date of this dividend is Thursday, October 3rd. Bodycote’s dividend payout ratio is presently 5,111.11%.
About Bodycote
Bodycote plc provides heat treatment and thermal processing services worldwide. It operates in two Aerospace, Defence & Energy; and Automotive & General Industrial segments. The company offers heat treatment services, including altering the microstructure of metals and alloys, such as steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, HIP diffusion bonding, hydrogen brazing, induction brazing, and vacuum and honeycomb brazing; and hot isostatic pressing (HIP) services, including isostatic pressing and HIP supporting services, as well as Powdermet technology, a manufacturing process used in the production of complex components using powder metallurgy.
Featured Articles
- Five stocks we like better than Bodycote
- There Are Different Types of Stock To Invest In
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- Investing in Construction Stocks
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.